Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria

@article{Agarwal2013AllergicBA,
  title={Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria},
  author={Ritesh Agarwal and Arunaloke Chakrabarti and A. Shah and D Gupta and Jacques F. Meis and Randeep Guleria and R Moss and David W. Denning},
  journal={Clinical \& Experimental Allergy},
  year={2013},
  volume={43},
  pages={850 - 873}
}
Allergic bronchopulmonary aspergillosis (ABPA) is an immunological pulmonary disorder caused by hypersensitivity to Aspergillus fumigatus, manifesting with poorly controlled asthma, recurrent pulmonary infiltrates and bronchiectasis. There are estimated to be in excess of four million patients affected world‐wide. The importance of recognizing ABPA relates to the improvement of patient symptoms, and delay in development or prevention of bronchiectasis, one manifestation of permanent lung damage… 

Allergic Bronchopulmonary Aspergillosis: Diagnostic and Treatment

TLDR
The only way to bypass limits and allow for an early diagnosis, is to assume ABPA in all patients with difficult-to-control asthma or cystic fibrosis patients, and they should then be screened for sensitization to A. fumigatus antigens and monitored more closely.

Allergic Bronchopulmonary Aspergillosis: Diagnostic and Treatment Challenges

TLDR
The only way to bypass limits and allow for an early diagnosis, is to assume ABPA in all patients with difficult-to-control asthma or cystic fibrosis patients, and they should then be screened for sensitization to A. fumigatus antigens and monitored more closely.

Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis

TLDR
Diagnosis of ABPA in CF patients should be sought in those with evidence of clinical and radiologic deterioration that is not attributable to another etiology, a markedly elevated total serum IgE level (while off steroid therapy) and evidence of A. fumigatus sensitization.

Allergic bronchopulmonary aspergillosis in asthma: epidemiological, clinical and therapeutic issues.

TLDR
The goals of managing ABPA include control of asthma, prevention and treatment of acute exacerbations, and preventing the development or progression of bronchiectasis, and there is a dire need for newer treatment approaches including oral antifungal agents and immunomodulatory therapy.

Allergic Bronchopulmonary Aspergillosis: A Perplexing Clinical Entity

TLDR
All patients with Aspergillus-sensitized asthma must be screened for ABPA, and AAS should always be looked for, as they help reduce the fungal load.

An Overview of Allergic Bronchopulmonary Aspergillosis; Diagnostic and Therapeutic Aspects

TLDR
Treatment for ABPA is dependent on the ABPA stage with asthma control, prevention and treatment of acute disease, and preventing the progression of bronchiectasis, according to the current review paper.

Allergic Bronchopulmonary Aspergillosis: Diagnosis and Treatment

TLDR
ABPA is a clinical spectrum of lung disease caused by the fungus Aspergillus characterized by repeated episodes of exacerbation with periods of remission, if untreated may progress to fibrotic lung disease.

Childhood allergic bronchopulmonary aspergillosis

TLDR
Although there are no trials regarding treatment of ABPA in children, steroids and itraconazole are the mainstay of therapy based on studies in adults and observational studies in children.

Allergic bronchopulmonary aspergillosis: Indian scenario

TLDR
ABPA is a clinical spectrum of lung disease caused by the fungus Aspergillus characterized by repeated episodes of exacerbation with periods of remission, if untreated may progress to fibrotic lung disease.
...

References

SHOWING 1-10 OF 295 REFERENCES

Concurrent allergic bronchopulmonary aspergillosis and aspergilloma: is it a more severe form of the disease?

  • A. Shah
  • Medicine, Biology
    European Respiratory Review
  • 2010
TLDR
The mould Aspergillus, a genus of spore forming fungi, affects the respiratory system in more ways than one and causes a wide spectrum of chest radiographic appearances, which could be either transient or permanent.

Diagnosis and treatment of allergic bronchopulmonary aspergillosis.

TLDR
The natural history and prognosis of ABPA are not well characterized but may be complicated by progression to bronchiectasis and pulmonary fibrosis, and consideration should be given to its use as a corticosteroid-sparing agent or for treatment of patients in whom corticosterone response is poor.

Pulmonary masses in allergic bronchopulmonary aspergillosis: mechanistic explanations.

TLDR
Patients with ABPA present with diverse radiographic manifestations, including finger-in-glove and toothpaste opacities, air-fluid levels from dilated bronchi, and tramline shadows from edematous bronchial walls.

What is the current place of azoles in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization

  • R. Agarwal
  • Medicine, Biology
    Expert review of respiratory medicine
  • 2012
TLDR
The current retrospective study evaluated the use of newer azoles (voriconazole and posaconazole) in adult asthmatic patients with either ABPA or severe asthma with fungal sensitization, and found the newer azole to improve asthma control and reduce the severity of ABPA.

Pathophysiology and immunology of allergic bronchopulmonary aspergillosis.

  • R. Moss
  • Medicine, Biology
    Medical mycology
  • 2005
TLDR
ABPA is characterized by marked local and systemic eosinophilia, an adaptive immune response with elevated levels of A. fumigatus-specific IgG, IgA and IgE antibodies, and a profound nonspecific IL-4-dependent elevation in total IgE.

Allergic bronchopulmonary aspergillosis in a patient with chronic obstructive pulmonary disease.

  • E. MirA. Shah
  • Medicine
    Primary care respiratory journal : journal of the General Practice Airways Group
  • 2012
TLDR
A 55-year-old male ex-smoker who presented with complaints of exertional breathlessness and productive cough for five years and an episode of haemoptysis four days prior to presentation had remarkable symptomatic improvement and was diagnosed as having concomitant COPD and ABPA-CB.

Allergic bronchopulmonary aspergillosis and related allergic syndromes.

  • C. HoganD. Denning
  • Medicine, Biology
    Seminars in respiratory and critical care medicine
  • 2011
TLDR
Most patients with ABPA and SAFS can be stabilized for long periods with inhaled corticosteroids and itraconazole or another antifungal agent, and second-line therapy data are scant, but it is shown that 70 to 80% of patients who tolerate either voriconazoles or posaconazoles also respond.

Allergic bronchopulmonary aspergillosis and Aspergillus infection in cystic fibrosis

  • R. Moss
  • Medicine, Biology
    Current opinion in pulmonary medicine
  • 2010
TLDR
Diagnosis of CF-ABPA remains difficult, but improvements in serologic assays are occurring, and new agents offer promise but await proper controlled trials of safety and efficacy.

Pictorial essay: Allergic bronchopulmonary aspergillosis

Allergic bronchopulmonary aspergillosis (ABPA) is the best-known allergic manifestation of Aspergillus-related hypersensitivity pulmonary disorders. Most patients present with poorly controlled
...